Given the inherent limitations of the FAERS database, potential confounders, and biases, our findings should be interpreted with caution
Upon completion of this course, the participant should be able to: Chapter 1: Diabetes Overview Chapter 2: Types of Diabetes Chapter 3: Diagnostic Testing Chapter 4: The Introduction of Semaglutide (Ozempic) Chapter 5: Antagonist/Agonist GLP-1, Ghrelin, and Leptin Chapter 6: Semaglutide Overview Chapter 7: Semaglutide, Diabetes, and Gastroparesis Chapter 8: Lifestyle Behavior Modification Chapter 9: References Maureen graduated nursing school in 1981 and has spent her years in the Emergency and Trauma field, including nursing positions as the Emergency Department Manager, Director of Staff Education, Trauma Coordinator, Cardiology Nurse Navigator, and Stroke Program Manager
If you are not seeing significant results (at least 5% of body mass lost) after taking semaglutide for 6 months, your doctor may wish to discuss alternative options with you
PMID 18177285
Public Awareness Campaigns: Educate the public that GLP-1 drugs are potent medical treatments for serious diseases, not cosmetic lifestyle products
Obesity 28 (1), 122131
